Characterization of an abnormal species of apolipoprotein B, apolipoprotein B-37, associated with familial hypobetalipoproteinemia.
about
Transgenic mice that overexpress mouse apolipoprotein B. Evidence that the DNA sequences controlling intestinal expression of the apolipoprotein B gene are distant from the structural geneA gene-targeted mouse model for familial hypobetalipoproteinemia. Low levels of apolipoprotein B mRNA in association with a nonsense mutation in exon 26 of the apolipoprotein B geneTargeted modification of the apolipoprotein B gene results in hypobetalipoproteinemia and developmental abnormalities in miceLow density lipoprotein undergoes oxidative modification in vivo.Genetic basis of lipoprotein disorders.Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).Use of immunoelectron microscopy and intestinal models to explore the elaboration of apolipoproteins required for intraenterocyte lipid transport.A truncated species of apolipoprotein B (B67) in a kindred with familial hypobetalipoproteinemia.Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantationFamilial hypobetalipoproteinemia caused by a mutation in the apolipoprotein B gene that results in a truncated species of apolipoprotein B (B-31). A unique mutation that helps to define the portion of the apolipoprotein B molecule required for the fFamilial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor bindingInference of a molecular defect of apolipoprotein B in hypobetalipoproteinemia by linkage analysis in a large kindredGenetic analysis of a kindred with familial hypobetalipoproteinemia. Evidence for two separate gene defects: one associated with an abnormal apolipoprotein B species, apolipoprotein B-37; and a second associated with low plasma concentrations of apoGenetic evidence from two families that the apolipoprotein B gene is not involved in abetalipoproteinemia.Modification of the apolipoprotein B gene in HepG2 cells by gene targeting.A genetic model for absent chylomicron formation: mice producing apolipoprotein B in the liver, but not in the intestine.The Holstein Friesian Lethal Haplotype 5 (HH5) Results from a Complete Deletion of TBF1M and Cholesterol Deficiency (CDH) from an ERV-(LTR) Insertion into the Coding Region of APOB.Truncated variants of apolipoprotein B cause hypobetalipoproteinaemiaMonogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism.Reading-frame restoration with an apolipoprotein B gene frameshift mutation.Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urineTranscriptional regulation of the apolipoprotein B100 gene: purification and characterization of trans-acting factor BRF-2.Human small-intestinal apolipoprotein B-48 oligosaccharide chains.The gut microbiota modulates host energy and lipid metabolism in mice.Biosynthetic precursor (214 kDa) of apolipoprotein B-48 is not secreted by Caco-2 cells and normal human intestine.DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis.Reading-frame restoration by transcriptional slippage at long stretches of adenine residues in mammalian cells.
P2860
Q28281569-BE884B4F-3330-4E36-B580-50AD11142D42Q28512923-29F47B2C-1713-4416-9FE1-051356629C08Q28584854-334D771F-C7D2-45F5-93D4-296E3B7F57DCQ33838672-08AA1616-0BCD-49DA-9E72-1B68387EFE2FQ33847743-D29D75FB-9EA7-4D96-B39A-2A9E897C7DBCQ33910842-6E3A7930-7CF2-483E-8048-57CFCDBD0EB3Q33924108-4C3E1C4C-2D82-4A63-990A-73C5A720115DQ34189158-62D34143-A250-4FEF-908C-B4FDB58781D1Q34225777-3B152224-0B67-4528-ABFA-72393617B85EQ34246106-17984C7A-32BC-438D-8E41-65E02850F70BQ34350695-6B6C2CE6-F787-4CEB-ACB2-DA67E31DB46AQ34561886-C6F6ACE8-F664-485C-8229-280CCBE65363Q34576724-C1CDD733-0C8C-40A8-A122-160F6A7D7A04Q35593754-17063DFF-BAE4-416E-85C4-1AADE82EF5B6Q35604201-2BFB8EBD-9120-4DA1-B85F-5A7072913DC6Q35769011-ADB3E92E-7668-4B6F-9956-54DA4AC3B088Q36003135-AC50E6E7-F1C0-4EE1-A5EF-D43DD207B9A1Q36065192-88D973FD-F3EF-4A37-A27E-F87658FDDBCEQ36359516-78E9A95D-263C-4FA9-9AED-3739A44209F2Q37324226-CFFF21C9-DB05-436E-8879-164AE645574FQ37361631-4886F3BB-84F1-4E8F-B8DD-FB79DEE95DF5Q38327727-500D5FBB-00B0-48F1-B468-BFEF4D081591Q38336544-9D182ACD-14D9-4E12-9A96-119E4B489E80Q39993460-E4D0AB71-C174-4E47-BBCF-407591358889Q41759289-B2F0FD3C-8200-4609-A07F-D398E72128F8Q46348843-6052BDA5-6A06-4A1F-983C-E3F932BF6F7AQ53969208-F312D30B-D1EA-43E7-A2C9-294AD9546A7E
P2860
Characterization of an abnormal species of apolipoprotein B, apolipoprotein B-37, associated with familial hypobetalipoproteinemia.
description
1987 nî lūn-bûn
@nan
1987 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Characterization of an abnorma ...... ilial hypobetalipoproteinemia.
@ast
Characterization of an abnorma ...... ilial hypobetalipoproteinemia.
@en
Characterization of an abnorma ...... ilial hypobetalipoproteinemia.
@nl
type
label
Characterization of an abnorma ...... ilial hypobetalipoproteinemia.
@ast
Characterization of an abnorma ...... ilial hypobetalipoproteinemia.
@en
Characterization of an abnorma ...... ilial hypobetalipoproteinemia.
@nl
prefLabel
Characterization of an abnorma ...... ilial hypobetalipoproteinemia.
@ast
Characterization of an abnorma ...... ilial hypobetalipoproteinemia.
@en
Characterization of an abnorma ...... ilial hypobetalipoproteinemia.
@nl
P2093
P2860
P356
P1476
Characterization of an abnorma ...... ilial hypobetalipoproteinemia.
@en
P2093
J L Witztum
L K Curtiss
S J Bertics
P2860
P304
P356
10.1172/JCI113025
P407
P577
1987-06-01T00:00:00Z